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Abstract The keratinocyte growth factor (KGF/FGF7),
produced by stromal cells, is a key paracrine mediator of
epithelial proliferation, diVerentiation and migration.
Expression of the growth factor is increased in wound heal-
ing and in hyperproliferative epithelial diseases, as a conse-
quence of the activation of dermal Wbroblasts by the
inXammatory microenvironment. The middle ear cholestea-
toma, an aural epidermal pathology characterized by kerati-
nocyte hyperproliferation and chronic inXammation, may
represent a model condition to study the epithelial-mesen-
chymal interactions. To develop an in vitro model for this
disease, we isolated and characterized human primary cul-
tures of Wbroblasts associated with the cholesteatoma
lesion, analyzing their secretory behaviour and degree of
diVerentiation or activation. Compared to the perilesional
or control normal Wbroblasts, all cultures derived from cho-
lesteatoma tissues were less proliferating and more diVer-
entiated and their highly variable activated phenotype
correlated with the secretion of KGF as well as of metallo-
proteases 2 and 9. Culture supernatants collected from the
cholesteatoma-associated Wbroblasts were able to increase
the proliferation and diVerentiation of human keratinocytes
assessed by the expression of Ki67 and keratin-1 markers.
The single crucial contribution of the KGF released by
Wbroblasts on the keratinocyte biological response was
shown by the speciWc, although partial, block induced by
inhibiting the KGF receptor or by immunoneutralizing the
growth factor. Altogether, these results suggest that the
activation of the stromal Wbroblasts present in the patholog-
ical tissue, and the consequent increased secretion of KGF,
play a crucial role in the deregulation of the epidermal pro-
liferation and diVerentiation.
Keywords Keratinocyte growth factor · Fibroblast 
growth factor · Cholesteatoma · Cultured human Wbroblasts · 
Metalloproteases
Introduction
The keratinocyte growth factor (KGF/FGF7) is a member
of the Wbroblast growth factor family and a major paracrine
mediator of the epidermal homeostasis through regulation
of the keratinocyte proliferation, diVerentiation and migra-
tion (Finch et al. 1989; Marchese et al. 1990; Ceccarelli
et al. 2007). Produced by stromal cells, KGF binds exclu-
sively to the KGFR, a splicing transcript variant of the
Wbroblast growth factor receptor 2 (FGFR2b) (Miki et al.
1992). In addition to its physiologic role, KGF is up-modu-
lated in its expression in human wound healing during the
process of re-epithelization (Marchese et al. 1995). In pre-
vious papers from our group, we have reported that KGF
expression is also increased in hyperproliferative epithelial
diseases, such as psoriasis and acanthoma, as a conse-
quence of the activation of dermal Wbroblasts by the inXam-
matory microenvironment (Kovacs et al. 2005, 2006).
These results are consistent with the current knowledge
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252 Histochem Cell Biol (2012) 138:251–269that, in diVerent epithelial pathological conditions and in
tumorigenesis, the activation of the stromal cells is able to
sustain the keratinocyte hyperproliferation and altered
diVerentiation through the secretion of soluble paracrine
growth factors and cytokines (Räsänen and Vaheri 2010).
Among the hyperproliferative epithelial diseases, the
middle ear cholesteatoma (CHO) is an aural lesion, which
may grow and invade the surrounding stroma, including
bone and middle/inner ear structures (Olszewska et al.
2004). Although diVerent studies have shown the invasive
and hyperproliferative behaviour of the CHO epidermal tis-
sue (Bujia et al. 1993; Vennix et al. 1996), very little is still
known about the molecular mechanisms involved in the
pathogenesis of the disease. Others and we have suggested
that the proliferation and migration of the keratinocytes in
CHO might be mediated by an altered release of autocrine
and paracrine growth factors and a modulated expression of
their receptors (Kojima et al. 1994; Tanaka et al. 1999;
Yetiser et al. 2002). Among them, KGF and KGFR expres-
sion appear up-modulated in CHO tissue (Kojima et al.
1996; Ishibashi et al. 1997; Yamamoto-Fukuda et al. 2003,
2010; Barbara et al. 2008; d’Alessandro et al. 2010) and the
eYcacy of a common therapeutic treatment of the lesion is
related to a down-modulation of the growth factor
(Yamamoto-Fukuda et al. 2008). Therefore, it is possible
that the activation of the stromal Wbroblasts associated to
the lesion and the consequent release of KGF could play a
role in the deregulation of the epidermal proliferation and
diVerentiation, which characterizes the CHO tissue.
The development of in vitro models of epithelial-mesen-
chymal interaction may greatly contribute to elucidate the
eVects mediated by the stromal Wbroblasts on the epithelial
cells and the molecular mechanisms involved in the CHO
pathogenesis. To this aim, in this study, we established and
characterized human primary cultures of CHO-associated
Wbroblasts analyzing their growth and secretory behaviour
and their degree of diVerentiation/activation. In addition, we
evaluated the ability of their culture supernatants to modulate
the biological response of human keratinocytes, demonstrat-
ing the key contribution of the KGF secreted in the medium
in modulating this response. Our results indicate that CHO-
associated Wbroblasts might be able to sustain the growth and
invasive behaviour of the lesion through the secretion of par-
acrine diVusible factors, such as KGF, and of pro-invasive
molecules, such as metalloproteases.
Materials and methods
Patients and tissue samples
Tissue samples were obtained from middle ear cholestea-
toma specimens (CHO-AFs) collected during surgical
procedures performed on 11 consecutive patients. The
control samples were obtained from skin of the medial
external auditory canal (MEAC-Fs) during surgical proce-
dure performed on a patient with otosclerosis and from
non-auricolar skin (NAS-Fs) by punch-biopsy performed
on a patient with abdominal aortic aneurysm. The clinical
and demographic characteristics of the enrolled patients
and site of sampling are described in Table 1. All patients
were extensively informed and gave written consent for
the investigations. The study was approved by the ethics
committee of the University Hospital where it was con-
ducted. Tissue samples were examined by toluidine blue
semithin sections and assessed independently by two
pathologists.
Cell cultures and treatments
Primary cultures of human Wbroblasts were obtained from
middle ear cholesteatoma specimens (CHO-AFs). Control
cultures were derived from perilesional tissue of cholesteat-
omatous patients (perilesional-Fs), from normal human
skin of the medial external auditory canal (MEAC-Fs) and
from non-auricolar skin (NAS-Fs).
Tissue samples were cut into small pieces, digested with
dispase 0.1 mg/ml and collagenase I 0.35 % for 45 min at
37 °C, pelleted, resuspended and maintained in Dulbecco’s
modiWed Eagle medium (DMEM) containing 10 % fetal
bovine serum (FBS) and antibiotics. Primary cultures were
obtained and propagated up to the second passage.
To induce Wbroblast diVerentiation, the cultures of CHO-
AFs were maintained in DMEM without serum for 48 h in
the presence of TGF 50 ng/ml (PeproTech Inc., Rocky
Hill, NY, USA).
Supernatants (SNs) obtained from primary cultured
CHO-AFs, MEAC-Fs, NAS-Fs and perilesional-Fs kept in
serum-free medium for 48 h were collected and frozen at
¡80 °C until use. SNs were also obtained from two primary
cultured CHO-AFs kept in serum-free medium in presence
of TGF 50 ng/ml for 48 h.
The human keratinocyte cell line HaCaT was cultured in
DMEM supplemented with 10 % FBS and antibiotics. Pri-
mary cultures of normal human keratinocytes (NHKs) were
derived from skin biopsies as described previously (Belle-
udi et al. 2011) and maintained in Medium 154-CF
(Cascade Biologics, Portland, OR, USA) supplemented
with Human Keratinocyte Growth Supplement (HKGS,
Cascade Biologics) plus antibiotics and Ca2+ 0,03 mM
(CascadeBiologics Inc.).
For proliferation assay, HaCaT cells were treated for
48 h at 37 °C with 20 ng/ml recombinant KGF (Upstate
Biotechnology, Lake Placid, NY, USA) or SNs collected
from cultured CHO-AFs, perilesional-Fs, MEAC-Fs and
NAS-Fs as above. For evaluation of the cellular diVerentiation,123























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































254 Histochem Cell Biol (2012) 138:251–269conXuent HaCaT cells were treated for 48 h at 37 °C with
20 ng/ml KGF or the SNs collected as above.
For inhibition of KGFR activity, HaCaT cells were pre-
incubated with a speciWc FGFR tyrosine kinase inhibitor
SU5402 25 M (Calbiochem, Nottingham, UK) for 1 h
before treatments with KGF or SNs in presence of SU5402.
To selectively block the KGF activity, we used a neutraliz-
ing rabbit polyclonal antibodies to KGF (C-19, Santa Cruz
Biotechnology, Santa Cruz, CA, USA) (10 g/ml in culture
medium).
ImmunoXuorescence
Cells grown on coverslips were Wxed with 4 % paraformal-
dehyde followed by treatment with 0.1 M glycine for
20 min at 25 °C and with 0.1 % Triton X-100 for additional
5 min at 25 °C to allow permeabilization. Cells were then
incubated with the following primary antibodies: anti-
vimentin (1:50 in PBS; Dako, Glostrup, Denmark), anti-
cytokeratins (1:50 in PBS; Dako), anti -SMA (1:50 in
PBS; Dako) monoclonal antibodies, anti-Ki67 (1:50 in
PBS; Zymed Laboratories, Inc, San Francisco, CA) and
anti-keratin 1 (1:50 in PBS; Covance, Emeryville, CA,
USA) rabbit polyclonal antibodies.
The primary antibodies were visualized, after appropri-
ate washing with PBS, by using goat anti-mouse IgG–FITC
(1:50 in PBS; Cappel Research Products, Durham, NC,
USA), goat anti-rabbit IgG–Texas Red (1:200 in PBS;
Jackson Immunoresearch Laboratories, West Grove, PA,
USA) and goat anti-rabbit IgG–FITC (1:500 in PBS; Cap-
pel Research Products), for 30 min at 25 °C. Nuclei were
stained with 4-6-diamido-2-phenylindole dihydrochlo-
ride (DAPI) (1:10,000 in PBS, Sigma Chemical Co.,
St. Louis, MO, USA). Coverslips were Wnally mounted
with Mowiol in PBS for observation.
Fluorescence signals were analyzed by conventional
Xuorescence or by scanning cells in series of 0.5 m
sequential sections with an ApoTome System (Zeiss,
Oberkochen, Germany) connected with an Axiovert 200
inverted microscope (Zeiss); image analysis was then per-
formed by the Axiovision software (Zeiss).
The percentage of Ki67- or K1- positive cells was ana-
lyzed counting for each treatment a total of 500 cells,
observed in ten microscopic Welds randomly taken from
three diVerent experiments. Results have been expressed as
mean values § SE.
Western blot analysis
Cells were lysed in a buVer containing 50 mM HEPES pH
7.5, 150 mM NaCl, 1 % glycerol, 1 % Triton X-100,
1.5 mM MgCl2, 5 mM EGTA, supplemented with protease
inhibitors (10 mg/ml aprotinin, 1 mM PMSF, 10 mg/ml
leupeptin), and phosphatase inhibitors (1 mM sodium
orthovanadate, 20 mM sodium pyrophosphate, 0.5 M NaF);
50 g of total protein were resolved under reducing condi-
tions by 8 % SDS-PAGE and transferred to reinforced
nitrocellulose (BA-S 83, Schleider and Schuell, Keene,
NH, USA). The membranes were blocked with 5 % non-fat
dry milk in PBS 0.1 % Tween 20, and incubated with anti-
KGF (H-73, Santa Cruz) polyclonal antibodies, followed
by enhanced chemiluminescence detection (ECL; Amer-
sham, Arlington Heights, IL). The membranes were rehy-
drated by being washed in PBS-Tween 20, stripped with
100 mM mercaptoethanol and 2 % SDS for 30 min at
55 °C, and probed again with anti-actin (Sigma) monoclo-
nal antibody, to estimate the protein equal loading.
Densitometric analysis was performed using Quantity
One Program (Bio-Rad Headquarters, Hercules, CA, USA).
BrieXy, the signal intensity for each band was calculated
and the background subtracted from experimental values.
The resulting values were then normalized and expressed as
fold increase with respect to the control and mean
values § SE from three diVerent experiments in triplicate.
Primers
Oligonucleotide primers for target genes and for the house-
keeping gene were chosen with the assistance of the Oligo
5.0 computer program (National Biosciences, Plymouth,
MN) and purchased from Invitrogen. The following prim-
ers were used: for KGF target gene: 5-CACCAGGCAGA
CAACAGACAT-3 (sense), 5-GTAAGTTCAGTTGCT
GTGACGCT-3 (anti-sense). For each primer pair, we per-
formed no-template control and no-reverse-transcriptase
control (RT negative) assays, which produced negligible
signals.
RNA extraction and cDNA synthesis
RNA was extracted using the TRIzol method (Invitrogen,
Carlsbad, CA) according to manufacturer’s instructions and
eluted with 0.1 % diethylpyrocarbonate (DEPC)-treated
water. Total RNA concentration was quantitated by spec-
trophotometry and the quality was assessed by measuring
the optical density ratio at 260/280 nm. RNA samples were
stored at ¡80 °C. After denaturation in DEPC-treated water
at 70 °C for 10 min, 1 g of total RNA was used to reverse
transcription using iScript™ cDNA synthesis kit (Bio-Rad)
according to manufacturer’s instructions.
PCR ampliWcation and real-time quantitation
Real-time PCR was performed using the iCycler Real-Time
Detection System (iQ5 Bio-Rad) with optimized PCR con-
ditions. The reaction was carried out in 96-well plate using123
Histochem Cell Biol (2012) 138:251–269 255iQ SYBR Green Supermix (Bio-Rad) adding forward and
reverse primers for each gene and 1 l of diluted template
cDNA to a Wnal reaction volume of 15 l. All assays
included a negative control and were replicated three times.
The thermal cycling programme was performed as follows:
an initial denaturation step at 95 °C for 3 min, followed by
45 cycles at 95 °C for 10 s and 60 °C for 30 s. Real-time
quantitation was performed with the help of the iCycler IQ
optical system software version 3.0a (Bio-Rad), according
to the manufacturer’s manual. The relative expression of
the housekeeping gene was used for standardizing the reac-
tion. The comparative threshold cycle (Ct) method was
applied to calculate the fold changes of expression com-
pared to control cells. Results are reported as
mean § standard deviation (SD) from three diVerent exper-
iments in triplicate.
Flow cytometry for cell cycle
For each culture, the Wbroblasts were plated sparsely, tryp-
sinized, pelleted and resuspended in 70 % ethanol in PBS
and stored at 4 °C overnight. Cells were washed with PBS,
resuspended in propidium iodide (PI) staining solution
(50 g/ml) and RNAse A (100 Kunitz/ml) (Miltenyi Biotec
GmbH, Bergisch Gladbach, Germany) and incubated in the
dark for 40 min at room temperature. At least 20,000 cells
for each culture were collected and analyzed with MACS-
Quant® Analyzer Xow cytometer (Miltenyi Biotec GmbH).
Cell cycle distribution was calculated with MACSQuan-
tify® software (Miltenyi Biotec GmbH).
Morphological analysis
For the Wbroblast morphological analysis, three diVerentia-
tion stages were evaluated: FI = small spindle shaped cell,
FII = small epithelioid cells, FIII = large epithelioid cells
(Bayreuther et al. 1988). The L:E diVerentiation index was
calculated analyzing the Wbroblasts in early (E: FI + FII)
and late (L: FII/FIII + FIII) diVerentiation state (Herskind
and Rodemann 2000). The culture samples were observed
on a Zeiss Axiovert 200 inverted microscope equipped with
diVerential interference contrast (DIC) optics. Quantitative
analysis was performed by counting, for each cell culture, a
total of at least 250 cells observed in Wve microscopic Welds
randomly taken from three diVerent experiments.
ELISA
Matrix metalloproteinases-2 (MMP-2) and -9 (MMP-9) in
cellular homogenates from CHO-AFs, MEAC-Fs, NAS-Fs
and perilesional-Fs were quantiWed using the human MMP-
2 ELISA kit and human MMP-9 ELISA kit (Quantikine®;
R&D Systems, Minneapolis, MN) according to the manu-
facturer’s protocol. Standard curves for each ELISA
experiment were prepared from duplicate wells with
increasing concentrations of MMP-2 (0–0.78–1.56–3.13–
6.25–12.5–25–50 ng/ml), or MMP-9 (0–0.312–0.625–
1.25–2.5–5–10 ng/ml). The results were normalized for the
number of cells contained in each sample and were
expressed as nanograms/1 £ 106 cells. KGF in the SNs col-
lected from the cultures was quantiWed using the human
KGF ELISA kit (Quantikine®; R&D Systems, Minneapo-
lis, MN) according to the manufacturer’s protocol. A stan-
dard curve for each ELISA experiment was prepared
from duplicate wells with increasing concentrations of KGF
(0–31.2–62.5–125–250–500–1,000–2,000 pg/ml), using the
protocol described above. The results were normalized for
the number of cells contained in each sample and were
expressed as picograms/1 £ 106 cells. Each sample was
analyzed in triplicate. Mann–Whitney test was performed
to evaluate signiWcant diVerences between samples.
P < 0.05 was considered statistically signiWcant.
Statistical methods
Mann–Whitney non-parametric test was used to compare
variables that do not assume Gaussian distribution. Stu-
dent’s t test was used to compare variables that assume
Gaussian distribution. All the correlation measures were
evaluated by the Pearson test (r) and by linear analysis of
regression curve. P values < 0.05 were assumed as statisti-
cally signiWcant.
Results
Establishment and characterization of primary cultures 
of Wbroblasts derived from cholesteatoma lesions 
and assessment of their diVerentiated phenotype
To analyze the behaviour of the stromal Wbroblasts associ-
ated with the cholesteatoma (CHO) hyperproliferative epi-
dermal disease, we isolated and propagated in culture
primary Wbroblasts obtained from middle ear CHO speci-
mens (CHO-AFs). For control samples, we established
Wbroblast cultures from the perilesional tissue of cholesteat-
omatous patients (perilesional-Fs) as well as from normal
human skin of the medial external auditory canal (MEAC-
Fs) and from non-auricolar skin (NAS-Fs). All the cells
were isolated and cultured as described in “Materials and
methods”. The number of the cultures analyzed throughout
the study and the clinical and demographic characteristics
of the enrolled patients and site of sampling are described
in Table 1.
The mesenchymal phenotype of the primary cultures and
their purity were Wrst conWrmed by immunoXuorescence123
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the intermediate Wlaments widely used as a Wbroblastic
marker: the analysis showed that, in all cultures, cells were
positive for vimentin staining, displaying a signal compati-
ble with the structure and localization of perinuclear cyto-
plasmic bundles of Wlaments (Fig. 1a). To rule out the
presence of epithelial cells in the cultures, cells were incu-
bated with anti-cytokeratins antibodies which recognize the
intermediate Wlaments of epithelial cells: no signal was
detected for cytokeratins (not shown) conWrming the mes-
enchymal phenotype of all the isolated primary cultures.
To analyze possible real diVerences in the biological
characteristics of our cultures, which may reXect the in vivo
behaviour, as well as to avoid in vitro diVerentiation, we
used all cultures at the second passage (P2). To evaluate the
degree of diVerentiation of the cells, Wrst we utilized and
adapted a morphological characterization (Bayreuther et al.
1988) proposed to distinguish in vitro diVerent diVerentia-
tion stages based on distinct morphological features: the
three stages (FI–FII–FIII) used in our classiWcation were
deWned as follows: FI = small spindle shaped cell,
FII = small epithelioid cells, FIII = large epithelioid cells.
The L:E diVerentiation index was calculated analyzing the
Wbroblasts in early (E: FI + FII) and late (L: FII/FIII + FIII)
diVerentiation stage (Herskind and Rodemann 2000). The
quantitative analysis revealed that the percentages of cells
of the FII and FIII groups, corresponding to more diVerenti-
ated stages, was highly variable among the CHO-AFs
(FII + FIII ranging from approximately 14 to 97 %), while
more homogeneous percentages were found in the controls
perilesional-Fs (ranging from approximately 58 to 78 %)
and in MEAC-Fs (40 %) or NAS-Fs (61 %). Consistent
with these percentages, also the L:E ratio was highly vari-
able in CHO-AFs, as reported in Table 1 (representative
examples are shown in Fig. 1b).
To evaluate the growth rate of the Wbroblast cultures, we
analyzed the cell cycle distribution by cytoXuorimetry as
described in “Materials and methods”. The results showed
that all the CHO-AFs cultures were characterized by a
lower percentage of cells in G2/M phase compared to con-
trol cultures (Table 1 and representative examples in
Fig. 1c) and that a reduction of the mitotic ability was fre-
quently related to a higher L:E ratio (Table 1).
Since it is well established that the activation of quies-
cent Wbroblasts leads to the acquisition of a more diVerenti-
ated phenotype and to an increased secretion of
extracellular matrix components and proteases (for a recent
review, see Räsänen and Vaheri 2010), we quantiWed by
ELISA test, in cellular homogenates of CHO-AFs and con-
trol Wbroblasts, the expression levels of the metallopro-
teases MMP-2 and MMP-9, which are known to be
modulated in cholesteatoma tissues (Schönermark et al.
1996; Shibosawa et al. 2000). The concentrations of both
MMP-2 and MMP-9 obtained from CHO-AFs were clearly
higher compared to MEAC-Fs, NAS-Fs and perilesional-Fs
homogenates (Fig. 1d; Table 1) and the CHO-AFs express-
ing increased amounts of MMPs correspond to less prolif-
erating cultures (Table 1).
Because the expression of -smooth muscle actin (-SMA)
is the most commonly used marker for activated and diVer-
entiated Wbroblasts (Räsänen and Vaheri 2010), to better
evaluate the diVerentiated phenotype of the CHO-AFs, we
analyzed by quantitative immunoXuorescence the percent-
age of cells positive for -SMA: as shown in Fig. 2a, the
immunoXuorescence signal appeared compatible with actin
bundles in the peripheral areas of the cytoplasm and was
enhanced in most of CHO-AFs. In addition, the percentage
of the -SMA-positive cells was higher in the CHO cultures
compared to perilesional-Fs and control cells (Fig. 2a). The
percentages of -SMA-positive cells were correlated with
the parameters of activation/diVerentiation used above: the
linear regression analysis showed a strong positive correlation
Fig. 1 Characterization of the primary cultures of cholesteatoma-
associated Wbroblasts. a ImmunoXuorescence analysis of expression of
the mesenchymal marker vimentin on representative example of diVer-
ent cultures of human Wbroblasts isolated from non-auricolar skin
(NAS-Fs), from normal skin of the medial external auditory canal
(MEAC-Fs), from middle ear cholesteatoma samples (CHO-AFs) and
from perilesional tissue of cholesteatomatous patients (perilesional-
Fs). in all cultures, the cells are positive for vimentin staining, which
appears as perinuclear cytoplasmic bundles of Wlaments. Nuclei are
stained with DAPI. Bar 20 m. b Morphologycal analysis of the pri-
mary cultures by diVerential interference contrast microscopy. Three
diVerentiation stages were deWned: FI, small spindle shaped cell (blue);
FII: small epithelioid cells (red); FIII: large epithelioid cells (green).
The Late:Early (L:E) ratio was calculated. The quantitative analysis
indicate that among the CHO-AFs the percentages of cells in the more
diVerentiated stages FII, FIII and the L:E ratio are highly variable. In
contrast, in the control perilesional-Fs and in MEAC-Fs or NAS-Fs the
percentages are homogenous. Bar 50 m. c Fibroblast cultures were
stained with PI and analyzed for cell cycle distribution with Xow
cytometry. The percentage of cells in G2/M results lower in CHO-AFs
compared to control cultures and the more quiescent phenotype fre-
quently corresponds to a higher L:E ratio. d MMP-2 and -9 quantita-
tion by ELISA test on cellular homogenates from CHO-AFs,
perilesional-Fs, MEAC-Fs, NAS-Fs. The MMP-2 and -9 levels in
CHO-AFs were detected in various amounts but are higher respect to
the cellular homogenates from control Wbroblasts. Results reported in
graph represent the mean values § SE. Mann–Withney test was
performed and signiWcance level has been deWned as described in
“Materials and methods”. Statistics for MMP-2: ^p = NS versus
MEAC-Fs and p = NS versus MEAC-Fs; *p < 0.05 versus MEAC-Fs;
**p < 0.01 versus MEAC-Fs; ***p < 0.01 versus MEAC-Fs and
p < 0.01 versus corresponding perilesional-Fs, ****p < 0.05 versus
MEAC-s and p < 0.05 versus corresponding perilesional-Fs. Statistics
for MMP-9: ^ p = NS versus MEAC-Fs; *p < 0.05 versus MEAC-Fs;
**p < 0.01 versus MEAC-Fs; ***p < 0.001 versus MEAC-Fs and
p < 0.001 versus corresponding perilesional-Fs, ****p < 0.05 versus
MEAC-s and p < 0.05 versus corresponding perilesional-Fs
123
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258 Histochem Cell Biol (2012) 138:251–269between the expression rate of -SMA and the L:E ratio
and the MMP-2 and -9 levels in all the primary Wbroblast
cultures (r: +0.91, f: p < 0.0001; r: +0.89, f: p < 0.00001;
r: +0.92, f: p < 0.00001), while a negative correlation was
found for -SMA with the G2/M data (r: ¡0.47, f:
p < 0.05) (Fig. 2b). Taken together, these results indicate
Fig. 2 Evaluation of -SMA expression. a ImmunoXuorescence anal-
ysis of the expression of the activation and diVerentiation markers anti
-SMA shows a signal localized in intracellular Wlaments, also orga-
nized in bundles, situated in the peripheral areas of the cytoplasm and
enhanced in most of CHO-AFs compared to control cells. The percent-
age of -SMA positive cells is higher in most CHO-AFs cultures
respect to perilesional-Fs and control cells. Nuclei are stained with
DAPI. Bar 20 m. Student’s t test was performed and signiWcance lev-
el has been deWned as described in “Materials and methods”. Results
reported in graph represent the mean values § SE. Statistics: ^p = NS
versus MEAC-Fs and p = NS versus MEAC-Fs; *p < 0.05 versus
MEAC-Fs; **p < 0.01 versus MEAC-Fs; ***p < 0.001 versus MEAC-
Fs and p < 0.001 versus corresponding perilesional-Fs, ****p < 0.01
versus MEAC-s and p < 0.01 versus corresponding perilesional-Fs.
b Correlation by linear regression analysis between -SMA positivity
rates and diVerentiation parameters. The L:E ratio and the metallopro-
teinases-2 and -9 levels, show a strong positive correlation with -SMA
expression in the primary Wbroblast cultures (r: +0.91, f: p < 0.0001;
r: +0.89, f: p < 0.00001; r: +0.92, f: p < 0.00001); in contrast the
fraction of cells in G2/M shows a negative correlation with -SMA
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Histochem Cell Biol (2012) 138:251–269 259that, although showing a great variability in morphological
shape and in biological behaviour, the CHO-AFs display a
more diVerentiated and activated phenotype than the perile-
sional-Fs, NAS-Fs and MEAC-Fs. Interestingly, some of
the CHO-AFs showing the diVerentiated/activated pheno-
type were isolated from cholesteatoma tissue samples char-
acterized by an extended dermal inXammatory inWltrate
(Table 1), assessed as previously described (d’Alessandro
et al. 2010).
Supernatants from CHO-AFs enhance keratinocyte 
proliferation and diVerentiation through KGF/FGF7 release
It is well known that there is a close interplay between the
stromal cells and the epithelial counterpart; this interaction
is mediated by soluble paracrine signals and secreted extra-
cellular matrix and proteases released from mesenchymal
cells which regulate the epithelial proliferation, diVerentia-
tion and migration (Räsänen and Vaheri 2010). In order to
analyze the possible biological activity of soluble factors
produced by the cultured CHO-AFs on a cellular epithelial
model, we treated the human keratinocyte HaCaT cell line
with the culture supernatants (SNs) collected from CHO-
AFs, NAS-Fs, MEAC-Fs and perilesional-Fs, to recreate in
vitro the interaction that occurs in vivo between derma and
epithelium. To Wrst analyze the proliferative eVect, HaCaT
cells were serum starved, treated with SNs from CHO-AFs
or from control cells for 48 h at 37 °C and then Wxed and
stained with antibodies against Ki67 antigen, which iden-
tify cycling cells (Fig. 3a). Quantitative immunoXuores-
cence analysis indicated that the percentage of cells
presenting positive nuclei was higher in keratinocytes
treated with SNs collected from CHO-AFs than in those
treated with SNs from NAS-Fs or MEAC-Fs. Moreover,
the SNs from perilesional-Fs induced a lower proliferating
rate than SNs collected from the corresponding lesional
cultures, but similar to SNs of control Wbroblasts (Fig. 3a).
The growth rate induced by the diVerent SNs was corre-
lated with the percentage of -SMA expression in the corre-
sponding primary Wbroblast cultures and the linear
regression analysis revealed a signiWcant positive correla-
tion (r: +0.66; f: p < 0.01) (Fig. 3a).
To evaluate the ability of the SNs to induce epithelial
diVerentiation, we analyzed the expression in keratinocytes
of the early diVerentiation marker keratin 1 (K1). To this
aim, HaCaT cells, which are known to undergo diVerentia-
tion following cell conXuence and stratiWcation (Ryle et al.
1989; Capone et al., 2000), were let to grow up to conXu-
ence, serum starved and treated with SNs as above before
Wxation and staining with anti-K1 antibodies (Fig. 3b).
Quantitative immunoXuorescence analysis showed that
SNs isolated from CHO-AFs induced a higher percentage
of K1 positive HaCaT cells than the SNs from NAS-Fs and
MEAC-Fs. Again, cells treated with SNs from perilesional-
Fs appeared less diVerentiated than the cells treated with
the SNs from the corresponding lesional cultures and simi-
lar to SNs from control cells (Fig. 3b). The percentage of
K1 positive HaCaT cells induced by the diVerent SNs was
correlated with -SMA expression as above and the linear
regression analysis showed a signiWcant positive correla-
tion (r: +0.67; f: p < 0.0001) (Fig. 3b). Altogether, these
results indicate that SNs from CHO-AFs have a greater
ability to induce epithelial cell proliferation and diVerentia-
tion in comparison with SNs from control Wbroblasts.
To verify whether the eVects induced by SNs treatment
on the HaCaT keratinocytes could be due to KGF released
by the Wbroblasts, the addition of the supernatants to the
cells was performed in the presence of the speciWc FGFR
tyrosine kinase inhibitor SU5402, similar to our previous in
vitro study (Visco et al. 2009). Treatment with recombinant
KGF 20 ng/ml in the presence or not of SU5402 was used
as control. Cells were then Wxed and stained with anti-Ki67
(Fig. 4a, c). The quantitative immunoXuorescence analysis
of cycling cells as above showed that, as expected (Belleudi
et al. 2007), KGF treatment induced an increase in the per-
centage of Ki67 positive cells that was signiWcantly
reduced by the presence of the KGFR inhibitor. Similarly,
SU5402 was able to inhibit the proliferative eVects for all
the SNs; however, the inhibition was much greater in the
keratinocytes treated with the SNs isolated from CHO-AFs
(Fig. 4a, c), suggesting that the proliferative activity of the
SNs derived from CHO-AFs could be most attributable to
an increased release of KGF in the culture medium. Com-
parable results were obtained by inhibiting the proliferative
eVect of the SNs through immunoblock of KGF with neu-
tralizing anti-KGF antibodies (Fig. 4b, c), unequivocally
indicating the relevance of the growth factor in the process.
Since it is known that KGF promotes keratinocyte diVer-
entiation (Capone et al. 2000; Belleudi et al. 2011) and we
have reported that in cholesteatoma tissue KGF up-modula-
tion is associated with keratinocyte diVerentiation (d’Ales-
sandro et al. 2010), to evaluate if the eVects of the SNs on
the expression of K1 could be ascribed to KGF, HaCaT
cells were treated as above in the presence of SU5402, Wxed
and stained with anti-K1 antibodies (Fig. 5a, c). The quanti-
tative analysis showed that the percentages of K1-positive
cells in response to treatment either with the growth factor
or the diVerent SNs was reduced in the presence of the
receptor inhibitor (Fig. 5a, c). The diVerentiative eVects
were more reduced by the inhibitor when the stimulation
was obtained with the SNs collected from CHO-AFs
(Fig. 5a, c) compared to the treatments with SNs from con-
trol Wbroblasts, further indicating that KGF might represent
the major paracrine eVector secreted by the activated
Wbroblasts associated with the cholesteatoma lesions. Again,
the immunoblock of KGF by the addition of neutralizing123
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antibodies led to an inhibition of the diVerentiative eVect
totally comparable to that obtained through the use of SU5402
(Fig. 5b, c), conWrming the key role played by KGF.
In order to demonstrate eYcient secretion of KGF in the
medium from the Wbroblast cultures, we performed Sand-
wich ELISA assay to analyze the KGF concentration in the
culture supernatants. The results indicate that all Wbroblast
cell cultures were able to produce KGF in various amounts
(Table 1; Fig. 6a). The concentrations of KGF obtained
from CHO-AFs were clearly higher compared to perile-
sional-Fs, MEAC-Fs and NAS-Fs SNs (Fig. 6a). Interest-
ingly, among the CHO-AFs, the #1410 whose SN
contained high amounts of KGF and showed the greater
ability to induce epithelial cell proliferation and diVerentia-
tion, corresponded to activated and diVerentiated Wbroblasts
characterized by the highest percentage of SMA-positive
cells and the greatest MMP levels. In contrast, the #1211
SN, which contained lower amounts of KGF, was collected
from Wbroblasts with a quiescent phenotype like control
cells.
The relationship between the diVerentiation and activa-
tion degree of the Wbroblast cultures and their ability to
secrete KGF was demonstrated by linear regression analy-
sis (Fig. 6a) that showed a positive correlation between the
-SMA expression rate of the cultures and the KGF levels
in diVerent SNs (r: +0.50; f: p < 0.05). In addition, the role
of KGF in the HaCaT cell stimulation induced by SNs
treatment was assessed by regression analysis (Fig. 6b): in
fact, the KGF levels in the SNs showed a positive correla-
tion with HaCaT proliferation (r: +0.58; f: p < 0.05) and
diVerentiation rates (r: +0.68; f: p < 0.05).
To better deWne the molecular mechanisms leading to
the increased KGF release in the culture supernatants from
CHO-AFs and to ascertain if the variable amounts of KGF
secreted in the medium would correspond to enhanced
expression of the growth factor at both transcriptional and
protein levels, we performed both RT-PCR and Western
blot analysis on a selection of cultured Wbroblasts charac-
terized by highly diVerent amounts of KGF secretion: the
results shown in Fig. 6c and d demonstrated, compared to
MEAC-Fs and perilesional-Fs, a clear increased mRNA
and protein expression in those CHO-AFs #2810 and
#0811, which displayed higher concentrations of the
growth factor detected in ELISA test (Fig. 6c, d). In accor-
dance with the conclusion that the enhanced KGF secretion
corresponds to a real transcriptional up-regulation, very low
levels of mRNA and protein expression were observed in
CHO-AFs #1211 characterized by a quiescent phenotype
and by a low amount of the growth factor released in the
medium (Fig. 6c, d).
To further demonstrate that the proliferative and diVer-
entiative eVects induced by the SNs collected from the acti-
vated lesional Wbroblasts represent a physiological/
pathological phenomenon occurring in middle ear epider-
mis, we performed a parallel set of experiments using
human primary cultured keratinocytes (HKs). As observed
for HaCaT cells, the SN from lesional Wbroblasts, but not
that from the perilesional cells, was able to increase either
the proliferation or the diVerentiation of the HKs (Fig. 7a, b).
The addition of anti-KGF neutralizing antibodies during the
incubation with the SNs as above caused a reduction of the
percentage of cycling and K1-positive cells to the untreated
levels (Fig. 7a, b), conWrming the key role played by KGF
in the keratinocyte stimulation.
To prove that the secretion of the KGF from the primary
cultures is related to the Wbroblast diVerentiation degree, we
used TGF treatment to induce in vitro diVerentiation of the
CHO-AFs cultures. In fact, it is well documented that TGF
promotes the diVerentiation and activation of quiescent stromal
Wbroblasts (Serini and Gabbiani 1999; De Wever et al. 2008).
We selected two CHO-AFs moderately diVerentiated, #2010
Fig. 3 Biological eVects induced by SNs from the Wbroblast cultures
on keratinocyte proliferation and diVerentiation. a HaCaT cells were
serum-starved, treated with SNs of diVerent primary cultures of Wbro-
blasts for 48 h at 37 °C, Wxed and immunostained with anti-Ki67 poly-
clonal antibodies, which identiWes cycling cells. Quantitative
immunoXuorescence analysis indicates that the percentage of cells pre-
senting positive nuclei was higher in HaCaT treated with SNs collected
from CHO-AFs respect to that treated with SNs from control cells. The
SNs from perilesional-Fs (#0811p and #1011p) induce a lower prolif-
erating rate respect to SNs from the corresponding lesional tissue
(#0811and #1011), but similar to SNs of control Wbroblasts NAS-Fs
and MEAC-Fs. At linear regression analysis, the proliferation rate in-
duced by the diVerent Wbroblast derived SNs on HaCaT cells shows a
positive correlation with -SMA expression in the corresponding pri-
mary Wbroblast cultures (r: +0.66; f: p < 0.01). Results reported in
graph represent the mean values § SE. Nuclei are stained with DAPI.
Bar 20 m. Student’s t test was performed and signiWcance level has
been deWned as described in “Materials and methods”. Statistics:
^p < 0.05 versus untreated and p = NS versus MEAC-Fs; *p < 0.05
versus untreated; **p < 0.05 versus MEAC-Fs; ***p < 0.01 versus
MEAC-Fs, ****p < 0.01 versus MEAC-Fs and p < 0.01 versus corre-
sponding perilesional-Fs; *****p < 0.01 versus MEAC-Fs and
p < 0.05 versus corresponding perilesional-Fs. b ConXuent HaCaT
cells were serum-starved, treated with SN as above, Wxed and immu-
nostained with anti-K1 polyclonal antibodies, which identify early
diVerentiated cells. Quantitative immunoXuorescence analysis reveals
that SNs collected from CHO-AFs induce a higher diVerentiation
respect to SNs from control cells. Cells treated with SNs from perile-
sional-Fs (#0811p and #1011p) appear less diVerentiated respect to
those treated with SNs from the corresponding lesional tissue
(#0811and #1011) and similar to SNs of NAS-Fs and MEAC-Fs. At
the linear regression analysis, the percentage of K1 positive keratino-
cytes in response to the diVerent SNs shows a positive correlation with
-SMA expression of the corresponding Wbroblast (r: +0.67; f:
p < 0.0001). Nuclei are stained with DAPI. Bar 50 m. Results report-
ed in graph represent the mean values § SE. Student’s t test was
performed and signiWcance level has been deWned as described in
“Materials and methods”. Statistics: *p < 0.05 versus untreated and
p = NS versus MEAC-Fs; **p < 0.05 versus untreated; ***p < 0.05
versus untreated and p = NS versus MEAC-Fs, ****p < 0.01 versus
untreated and p < 0.01 versus MEAC-Fs; *****p < 0.05 versus
MEAC-Fs and p < 0.05 versus corresponding perilesional-Fs123
262 Histochem Cell Biol (2012) 138:251–269and #2810, and we treated them with TGF 50 ng/ml for
48 h before Wxation and immunostaining with anti -SMA
antibody as above. The quantitative immunoXuorescence
analysis showed that TGF treatment induced an increase in
the number of -SMA positive cells in both cultures
(Fig. 8a). To verify if the most diVerentiated phenotype
induced by TGF treatment could correspond to a greater
capacity of the Wbroblasts to stimulate the epithelial cells,
HaCaT keratinocytes were serum starved and incubated with
the SNs collected from the TGF treated cultures before Wxa-
tion and staining with anti-Ki67 or with anti-K1 antibodies.
The quantitative analysis revealed that SNs obtained from
CHO-AFs stimulated with TGF had a greater capacity to
induce HaCaT cell proliferation and diVerentiation than SNs
Fig. 4 Reduction of the SN proliferation eVects by inhibition of the
KGFR activity or block of the KGF binding to the receptor. HaCaT
cells were serum-starved, treated with SNs or with KGF for 48 h at
37 °C in presence of the speciWc FGFR tyrosine kinase inhibitor
SU5402 (a) or of the neutralizing anti-KGF antibodies (b), Wxed and
immunostained with anti-Ki67 polyclonal antibodies. Quantitative
immunoXuorescence analysis indicates that inhibition of the KGFR
activity as well as block of the KGF binding to the receptor induce a
reduction in the percentage of cycling cells in response to the diVerent
SNs. The reduction is more evident after treatment with SNs from
CHO-AFs, as well as after KGF treatment, respect to SNs from control
cells. Nuclei are stained with DAPI. Bar 20 m. c Results reported in
graph represent the mean values § SE. Student’s t test was performed
and signiWcance level has been deWned as described in “Materials and
methods”: Statistics: (left): ^p = NS versus corresponding untreated;
*p < 0.05 versus corresponding untreated; **p < 0.01 versus corre-
sponding untreated; (right): ^ p = NS versus corresponding untreated;
*p < 0.01 versus corresponding untreated; **p < 0.05 versus corre-

















































































































































































Histochem Cell Biol (2012) 138:251–269 263isolated from unstimulated CHO-AFs (Fig. 8b). Again, this
induction was reduced in the presence of the KGFR inhibitor
SU5402, suggesting that the eVects on the keratinocytes
would be mostly mediated by the paracrine release of KGF
(Fig. 8b). In agreement with this hypothesis, sandwich
ELISA assay performed on these SNs demonstrated that the
enhancement in proliferation and diVerentiation observed
with the SNs from stimulated CHO-AFs is probably medi-
ated by an increased release of KGF in the medium (Fig. 8c).
Altogether, these results suggest that the CHO-AFs are
able to sustain the cholesteatoma growth and altered diVer-
entiation through the secretion of paracrine diVusible fac-
tors and that, among them, KGF might represent one of the
major eVectors.
Fig. 5 Reduction of the SN diVerentiation eVects by inhibition of the
KGFR activity or block of the KGF binding to the receptor. ConXuent
HaCaT cells were serum-starved, treated with SN or with KGF in pres-
ence of SU5402 (a) or anti-KGF antibodies (b) as above, Wxed and
immunostained with anti-K1 polyclonal antibodies. Quantitative
immunoXuorescence analysis shows that inhibition of KGFR activity
as well as block of the KGF binding to the receptor reduce the diVer-
entiation marker expression induced by the diVerent SNs. The reduc-
tion is more evident in HaCaT cells treated with SNs from CHO-AFs
and is similar to that observed for KGF treatment. Nuclei are stained
with DAPI. Bar 50 m. c Results reported in graph represent the mean
values § SE. Student’s t test was performed and signiWcance level has
been deWned as described in “Materials and method”. Statistics: (left):
^p = NS versus corresponding untreated cells; *p < 0.05 versus corre-
sponding untreated cells; **p < 0.01 versus corresponding untreated
cells; (right): ^ p = NS versus corresponding untreated cells; *p < 0.05














































































































































































264 Histochem Cell Biol (2012) 138:251–269Fig. 6 KGF expression and secretion in the culture SNs. a KGF-quan-
titation by ELISA test on SNs from the diVerent cultures of Wbroblasts.
The KGF levels released in the CHO-AFs medium are variable but
higher than in the SNs from control cells. The KGF amounts in diVer-
ent SNs show a positive correlation with -SMA expression in the cor-
responding primary Wbroblast cultures (r: +0.50; f: p < 0.05). Results
reported in graph represent the mean values § SE. Mann–Withney test
was performed and signiWcance level has been deWned as described in
“Materials and methods”. Statistics: ^p = NS versus MEAC-Fs;
*p < 0.05 versus MEAC-Fs; **p < 0.01 versus MEAC-Fs;
***p < 0.01 versus MEAC-Fs and p < 0.01 versus corresponding per-
ilesional-Fs. b In HaCaT cells treated with the diVerent SNs, the pro-
liferation rate and the percentage of K1 positive cells show a positive
correlation with KGF levels released in the SNs (r: +0.58 and +0.68,
respectively; p < 0.05). c KGF mRNA transcript levels were quanti-
tated by real-time PCR: a clear fold increase in KGF mRNA expression
is observed in lesional SNs compared to MEAC-Fs and perilesional-
Fs. d Western blot analysis on the cell lysates shows that the speciWc
band corresponding to KGF protein is increased in lesional Fs. The
equal loading was assessed with anti-actin antibody. Statistics for the
densitometric analysis: *p < 0.05 versus MEAC-Fs; **p < 0.01 versus
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In the last few years, it has been widely recognized that the
dermal Wbroblasts in an inXammatory microenvironment
play a crucial role in the deregulation of the keratinocyte
growth leading to epidermal hyperproliferation. Due to the
diYculties in studying these complex epithelial-mesenchy-
mal interactions in vivo, many eVorts have been devoted to
Fig. 7 Proliferative and diVerentiative eVects induced by SNs from
the Wbroblast cultures on primary cultured human keratinocytes. HKs
were serum-starved, treated with SNs for 48 h at 37 °C, Wxed and
immunostained with anti-Ki67 (a) or with anti-K1 polyclonal antibod-
ies (b), also in the in presence of netralizing anti-KGF antibodies as
above. Quantitative immunoXuorescence analysis (c) indicates that the
percentage of Ki67-positive or K1-positive cells was higher in HKs
treated with SNs collected from CHO-AFs in respect to that treated
with SNs from control cells and that the block of the KGF binding to
the receptor by addition of anti-KGF antibodies reduces the eVects of
SNs. Nuclei are stained with DAPI. Bar 20 m. Statistics: (left):
^p = NS versus corresponding untreated cells; *p < 0.05 versus corre-
sponding untreated cells; **p < 0.01 versus corresponding untreated
cells; (right): ^p = NS versus corresponding untreated cells; *p < 0.05









































































































266 Histochem Cell Biol (2012) 138:251–269develop in vitro models for the analysis of the molecular
mechanisms and autocrine or paracrine loops involved. The
cholesteatoma of the middle ear, being characterized by
keratinocyte hyperproliferation and chronic inXammation,
represents a model pathology to study the pathogenesis of
epithelial non-neoplastic diseases, in which activation of
the stromal cells sustains the hyperproliferation and meta-
plastic altered diVerentiation. Similarly to the experimental
studies conducted for other pathological conditions, diVer-
ent in vitro models have been developed also for the choles-
teatoma disease: however, most of them aimed to culture
and analyze cholesteatoma-derived keratinocytes, which
appear to retain in vitro the altered behaviour observed in
vivo (Cheshire et al. 1995; Albers-op t’ Hof et al. 2002;
Hilton et al. 2011). The only 3D co-culture model, devel-
oped using both primary keratinocytes and Wbroblasts from
a b
c123
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 the cholesteatoma tissue, was useful to investigate the cyto-
keratin protein proWle and metaplastic behaviour of the
lesional epidermal cells and to ascertain the importance of
the Wbroblasts in the optimization of the in vitro system
(Raynov et al. 2008); however, the study was not attempted
to address the potential activation of the stromal compo-
nents. Therefore, to investigate if also the cholesteatoma-asso-
ciated Wbroblasts might possess biological characteristics,
which distinguish them form the normal quiescent Wbro-
blasts and which could be retained at early passages in cul-
ture, in this study, we focused our attention to these cells,
analyzing their secretory behaviour and their degree of
diVerentiation or activation. We found that, compared to
the perilesional or control normal Wbroblasts, all cultures
derived from cholesteatoma samples were less proliferating
and more diVerentiated; moreover, although very variable
among the cultures, the diVerentiated phenotype well corre-
lated with an activated state, shown by MMP-2 and MMP-9
secretion, demonstrating that also in a non-neoplastic con-
text, such as the cholesteatoma disease, the associated
Wbroblasts might exert a pathological role through biologi-
cal functions which are maintained in culture.
Among the growth factors and cytokines which may
play a role in the development of the cholesteatoma dis-
ease, as well as in other hyperproliferative epithelial pathol-
ogies, KGF appears a key molecular eVector (Kojima et al.
1996; Ishibashi et al. 1997; Yamamoto-Fukuda et al. 2003,
2010; Barbara et al. 2008; d’Alessandro et al. 2010) and a
possible target or biomarker for therapeutic intervention
(Yamamoto-Fukuda et al. 2008). Many studies have
reported that the expression of KGF is up-modulated in
Fig. 8 Evaluation of biological eVects induced on HaCaT cells by SNs
from CHO-AFs stimulated with TGF. a Two selected cultures of
CHO-AFs, #2010 and #2810, were treated with TGF for 48 h at 37 °C
and then Wxed and stained with anti--SMA. Quantitative immunoXu-
orescence analysis of the percentage of -SMA positive cells shows
that, respect to untreated cells, TGF treatment induces an increase of
the -SMA positive cells in both cultures. Nuclei are stained with
DAPI Bar 20 m. Results reported in graph represent the mean
values § SE. Student’s t test was performed and signiWcance level has
been deWned as described in “Materials and methods”: Statistics:
*p < 0.05 versus untreated. b HaCaT cells were serum-starved, treated
for 48 h at 37 °C with the SN from #2010 and #2810 cultures treated
with TGF as above. The treatments were performed also in the pres-
ence of the KGFR inhibitor SU5402. The cells were then Wxed and
immunostained with anti-Ki67 or with anti-K1 polyclonal antibodies.
Quantitative immunoXuorescence analysis of the Ki67 or K1 positive
cells shows that the SNs from cultures treated with TGF induce an en-
hance the proliferation and diVerentiation of HaCaT cells respect to the
SNs from untreated cultures. Inhibition of the KGFR activity reduces
the eVects of SNs. Nuclei are stained with DAPI. Bars 20 m (left pan-
el) and 50 m (right panel). Results reported in graph represent the
mean values § SE. Student’s t test was performed and signiWcance
level has been deWned as described in materials and methods. Statistics
for proliferation analysis: *p < 0.05 versus SNs from unstimulated
CHO-AFs, **p < 0.05 versus SNs from unstimulated #2010 and
p < 0.01 versus SNs from TGF stimulated #2010, ***p < 0.05 versus
SNs from unstimulated and TGF stimulated #2810. Statistics for
diVerentiation analysis: * p < 0.01 versus SNs from unstimulated
CHO-AFs, **p < 0.05 versus SNs from unstimulated CHO-AFs and
p < 0.01 versus SNs from TGFb stimulated CHO-AFs. c KGF-quanti-
tation by ELISA test on SNs from #2010 and #2810 cultures treated
with TGF as above. In both cultures the amount of KGF released in
the medium is higher in SNs from TGF treated cells respect to the
SNs from untreated cells. Results reported in graph represent the mean
values § SE. Mann–Withney test was performed and signiWcance lev-
el has been deWned as described in “Materials and methods”. Statistics:
*p < 0.05 and **p < 0.01 versus untreated
Fig. 9 Schematic drawing of the proposed role of the cholesteatoma-
associated Wbroblasts (CHO-AFs) in the deregulation of epidermal
proliferation and diVerentiation through a paracrine loop involving
secretion of KGF: in the pathological framework (right panel), the
CHO-AFs, activated by growth factors and cytokines (such as TGF)
released by inXammatory cells, produce an increased amount of KGF
compared to the physiological conditions (left panel). Through bind-
ing to its receptor KGFR, the growth factor increases keratinocyte pro-
liferation and diVerentiation. The activated CHO-AFs release in the
stroma also enhanced levels of MMPs which contribute in the remod-
eling and degradation of the extracellular matrix123
268 Histochem Cell Biol (2012) 138:251–269cholesteatoma, but none of them was aimed to analyze in
detail the contribution of the KGF-secreting Wbroblasts to
the disease. Here, through the evaluation of the capacity of
the culture supernatants to modulate the biological response
in human keratinocytes in the presence of the KGFR inhib-
itor, we demonstrated the single key contribution of the
KGF released in the medium in deregulating the prolifera-
tive and diVerentiative response. Moreover, the variable
amount of KGF detected in the diVerent supernatants well
correlated with the quiescent or diVerentiated/activated
phenotype of the cultured Wbroblasts; this correlation is fur-
ther demonstrated by the increase in KGF production
observed following the widely used triggering of diVerenti-
ation by TGF treatment. Therefore, as depicted in the
schematic drawing in Fig. 9, the activation of the stromal
Wbroblasts present in the pathological tissue and the conse-
quent increased secretion of KGF appear to play a crucial
role in the deregulation of the epidermal proliferation and
diVerentiation which characterizes the cholesteatoma tis-
sue. Interestingly, we observed that the CHO-AFs showing
the diVerentiated/activated phenotype were isolated from
cholesteatoma tissue samples characterized by an extended
dermal inXammatory inWltrate, assessed as described in our
previous study (d’Alessandro et al. 2010), suggesting that
the variability of the phenotypic changes in the diVerent
Wbroblast populations would reXect the level of tissue
inXammation. Therefore, we propose that this model might
be very useful to evaluate the unknown pathogenetic role of
the stroma perimatrix component of the cholesteatoma
lesion and might contribute in general for a better under-
standing of the epithelial-mesenchymal interactions. More-
over, it is possible to assume that this model could be
utilized for the in vitro assessment of the eYcacy of thera-
peutic strategies directed to interfere with the pathological
paracrine loops.
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